326 related articles for article (PubMed ID: 31739258)
1. Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer.
Sui Y; Li Y; Li Y; Jin H; Zheng Y; Huang W; Chen S
J Photochem Photobiol B; 2020 Jan; 202():111669. PubMed ID: 31739258
[TBL] [Abstract][Full Text] [Related]
2. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis.
Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X
ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies.
Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M
MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging.
Li J; You J; Dai Y; Shi M; Han C; Xu K
Anal Chem; 2014 Nov; 86(22):11306-11. PubMed ID: 25338209
[TBL] [Abstract][Full Text] [Related]
5. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
[TBL] [Abstract][Full Text] [Related]
6. PEG coated and doxorubicin loaded multimodal Gadolinium oxide nanoparticles for simultaneous drug delivery and imaging applications.
Kumar S; Meena VK; Hazari PP; Sharma RK
Int J Pharm; 2017 Jul; 527(1-2):142-150. PubMed ID: 28506803
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of Gadolinium Oxide Nanoparticle (Gd
Mekuria SL; Debele TA; Tsai HC
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6782-6795. PubMed ID: 28164704
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent.
Dai Y; Wu C; Wang S; Li Q; Zhang M; Li J; Xu K
Nanomedicine; 2018 Feb; 14(2):547-555. PubMed ID: 29253637
[TBL] [Abstract][Full Text] [Related]
9.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
10. Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene glycol)/Arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres as an Enhanced T
Kuang Y; Cao Y; Liu M; Zu G; Zhang Y; Zhang Y; Pei R
ACS Appl Mater Interfaces; 2018 Aug; 10(31):26099-26107. PubMed ID: 30016059
[TBL] [Abstract][Full Text] [Related]
11. Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo.
Tian X; Yang F; Yang C; Peng Y; Chen D; Zhu J; He F; Li L; Chen X
Int J Nanomedicine; 2014; 9():4043-53. PubMed ID: 25187708
[TBL] [Abstract][Full Text] [Related]
12. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X
Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703
[TBL] [Abstract][Full Text] [Related]
13. T
Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
[TBL] [Abstract][Full Text] [Related]
14. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle.
Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K
Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342
[TBL] [Abstract][Full Text] [Related]
15. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
16. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
17. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
Li X; Xia S; Zhou W; Ji R; Zhan W
Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
[TBL] [Abstract][Full Text] [Related]
18. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
19. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging.
Li J; Zheng L; Cai H; Sun W; Shen M; Zhang G; Shi X
Biomaterials; 2013 Nov; 34(33):8382-92. PubMed ID: 23932250
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
